ASX shares to buy for the Omicron COVID outbreak

Jitters over the Omicron COVID mutation continue to rock markets and a handful of ASX shares could represent the best …

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Jitters over the Omicron COVID mutation continue to rock markets and a handful of ASX shares could represent the best place to seek shelter.

This is despite the fact that renewed social and border restrictions is likely to take the wind out of the S&P/ASX 200 Index (Index:^AXJO).

The more infectious Omicron variant has already hit our shores and it is only a matter of time before it surfaces in the US.

ASX shares Microscope looks at an Omicron piece of jigsaw puzzle

Image source: Getty Images

Should ASX investors fear new COVID outbreak?

We won't know for weeks if Omicron is resistant to current vaccines or how severe the new strain is. The good news is that we are unlikely to see a repeat of the previous harsh lockdowns that derail economic growth.

However, ASX share investors shouldn't be too quick to celebrate, according to Macquarie Group Ltd (ASX: MQG).

"We do not expect the same level of volatility seen at the start of the pandemic, as the world has already adapted to life in a pandemic," said the broker.

"But given central banks were tapering plus diminishing fiscal stimulus and generally already high asset prices, there is a risk equity market volatility is higher than during COVID waves over the last year."

ASX shares climbing the Omicron wall of worry

In other words, while the world is better prepared to deal with COVID mutations, central banks have run out of ammo to keep supporting risk assets.

Even before Omicron, ASX share investors were already fretting over surging cases in parts of Europe. Countries like Austria and Germany were reintroducing restrictions as winter gets into full swing to contain the outbreak.

But this isn't time to throw in the towel. Macquarie has identified the ASX shares that could be beneficiaries of COVID, particularly as US cases rise.

One COVID matrix to watch

"We calculated a COVID capture ratio as the ratio of relative returns when US COVID cases were decelerating in 2021 divided by returns when cases were accelerating," explained Macquarie.

"Like a Beta, this ratio indicates the sensitivity of relative performance to changes in COVID cases."

A ratio below 1 indicates an ASX share that is more likely to outperform when COVID infections rise. A figure above 1 indicates the opposite.

Best and worst ASX shares to shelter from Omicron

Among the large cap ASX shares, those with a ratio below 1 include the Goodman Group (ASX GMG) share price and Brambles Limited (ASX: BXB) share price.

Others in the same camp are the ASX Ltd (ASX: ASX) share price and Northern Star Resources Ltd (ASX: NST) share price – just to name a few.

On the flipside, the Omicron losers include the Woodside Petroleum Limited (ASX: WPL) share price, Nine Entertainment Co Holdings Ltd (ASX: NEC) share price and Vicinity Centres (ASX: VCX) share price.

Banks and financial shares are also among the losers. These include the Westpac Banking Corp (ASX: WBC) share price, Commonwealth Bank of Australia (ASX: CBA) share price, Virgin Money UK CDI (ASX: VUK) share price and AMP Ltd (ASX: AMP) share price.

More on Broker Notes

Woman using a pen on a digital stock market chart in an office.
Broker Notes

Could these ASX stocks double by the end of 2026?

These 5 stocks could be undervalued.

Read more »

An investor wearing a dressing gown and holding a cup of coffee in a yellow mug gives a satisfied smile.
Broker Notes

7 ASX 200 shares just upgraded to strong buy ratings

Looking for inspiration after the March sell-off?

Read more »

A couple sitting in their living room and checking their finances.
Broker Notes

Buy, hold, sell: CSL, Magellan, and Woodside shares

Do analysts think these blue-chips are in the buy zone? Let's find out.

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Up 32% this week, are Guzman Y Gomez shares a good buy today?

A leading analyst delivers his outlook for Guzman Y Gomez shares.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
Broker Notes

Buy, hold, or sell? Bubs, Soul Patts, and Endeavour shares

Experts have reviewed their ratings on these ASX shares.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares tipped to grow 100% or more in the next 12 months

These stocks across three sectors could be deeply undervalued, analysts say.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy Capstone Copper shares today

A leading analyst expects more outperformance from Capstone Copper’s surging shares. But why?

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Broker Notes

What is this broker's view on Magellan Financial Group after yesterday's disappointing results

Where to next for this funds manager?

Read more »